SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

SHB.B

215.8

-1.28%↓

SWED.A

317.6

-0.94%↓

SCA.A

125.2

-0.95%↓

EVO

619

+2.76%↑

SKF.B

222.5

-0.27%↓

Search

Kinnevik AB (Class B)

Închisă

49.62 1.35

Rezumat

Modificarea prețului

24h

Curent

Minim

49.4

Maxim

50.64

Indicatori cheie

By Trading Economics

Venit

-2.3B

-1.7B

Vânzări

1M

3M

P/E

Medie Sector

181.333

55.155

EPS

2.26

Marjă de profit

-55,866.667

Angajați

47

EBITDA

-3.5B

-2.8B

Dividende

By Dow Jones

Următoarele câștiguri

16 apr. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-11B

14B

Deschiderea anterioară

48.27

Închiderea anterioară

49.62

Kinnevik AB (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 apr. 2026, 23:17 UTC

Câștiguri

Samsung Forecasts Record First-Quarter Operating Profit

6 apr. 2026, 23:00 UTC

Acțiuni populare

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr. 2026, 22:13 UTC

Principalele dinamici ale pieței

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr. 2026, 21:46 UTC

Achiziții, Fuziuni, Preluări

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr. 2026, 17:09 UTC

Principalele dinamici ale pieței

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr. 2026, 16:56 UTC

Evenimente importante

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr. 2026, 14:47 UTC

Principalele dinamici ale pieței

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 apr. 2026, 00:00 UTC

Evenimente importante

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 apr. 2026, 23:58 UTC

Market Talk
Evenimente importante

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 apr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr. 2026, 18:36 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 17:59 UTC

Market Talk
Evenimente importante

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr. 2026, 17:13 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 apr. 2026, 14:59 UTC

Câștiguri

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparație

Modificare preț

Kinnevik AB (Class B) Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Kinnevik AB (Class B)

Kinnevik AB is a venture capital firm specializing in investments in early to late venture and growth capital. The firm also prefers indirect investments in venture capital funds. It prefers to invest in digital consumer business, education, communication, e-commerce and marketplaces, entertainment, healthcare, and financial services but may also invest in other areas. The firm invests worldwide, especially in Europe with a focus on the Nordics, Latin America, Asia, Australia, Africa, and North America. The firm looks for disruptive, technology-enabled and value-added consumer services in developed and emerging markets. It takes an active role on the boards of its subsidiaries and associated companies. It acts as a long-term lead shareholder in large listed entities. Kinnevik AB was founded in 1936 and is based in Stockholm, Sweden and additional office in London, United Kingdom. Kinnevik AB was formerly known as Investment AB Kinnevik.
help-icon Live chat